Advanced Solid Tumors: YL201 Treatment Study

We are investigating a new treatment called YL201 for patients with advanced solid tumors. The goal is to see how effective and safe it is compared to current options.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut De Cancerologie De L Ouest
Medical Oncology
Avignon, France
Centre Hospitalier Universitaire De Bordeaux
Department of Medical Oncology
Bordeaux, France
Centre Hospitalier Regional De Marseille
CEPCM-CLIPP
Marseille, France

Sponsor: Medilink Therapeutics (Suzhou) Co. Ltd.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.